At the end of 2019, a new disease recognized such as severe acute respiratory syndrome
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …

The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …

After rigorous clinical trialsof vaccines for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have established safety and efficacy, and after vaccines are deployed …

The teams of researchers scrambling to develop a coronavirus disease 2019 (COVID-19)
vaccine clearly face some big challenges, both scientific and logistical. One of the most …

Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19)
pandemic and to help the return to pre-pandemic normalcy. A great many vaccine …

The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …

A novel coronavirus (CoV), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), emerged in late 2019 in Wuhan, China and has since spread as a global pandemic. Safe …

Evaluating and Deploying Covid-19 Vaccines New entities and investments have aided the
pursuit of Covid-19 vaccines. Moving forward, relying on time-tested mechanisms for …

After the recent announcement of COVID-19 vaccine efficacy in clinical trials by several
manufacturers for protection against severe disease, a comprehensive post-efficacy strategy …